Clinical Trials on Secondary Central Nervous System Non-Hodgkin Lymphoma
Total 88206 results
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Auxilio Mutuo Cancer CenterCompletedRefractory Aggressive Non-Hodgkin's Lymphoma | Relapsing Aggressive Non-Hodgkin's Lymphoma
-
Jonsson Comprehensive Cancer CenterGilead SciencesTerminatedB-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin Lymphoma | Absence of Signs or Symptoms | Digestive System Signs and Symptoms | Indolent Adult Non-Hodgkin LymphomaUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid TumorCanada, United States
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory B-cell Non-Hodgkin's LymphomaChina
-
Montefiore Medical CenterNational Cancer Institute (NCI)Completed
-
Stanford UniversityKite PharmaRecruitingNon-Hodgkin Lymphoma | Large B-cell LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingB-Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
University of California, San FranciscoTerminated
-
Versailles HospitalNot yet recruitingVaccination Failure | Non-hodgkin Lymphoma,B Cell
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingRecurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...United States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieUnknownUnresectable Solid Neoplasm | Recurrent Solid Neoplasm | Refractory Mantle Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Advanced Solid Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance
-
Jurgen BarthSponsor GmbHActive, not recruitingNon-Hodgkin's Lymphoma | Lymphocytic Lymphoma | Marginal Zone Lymphomas | Follicular Lymphomas | Immunocytomas | Mantle-Cell LymphomasGermany
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownLymphoma, FollicularChina
-
Chinese PLA General HospitalRecruitingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsAdvanced Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaChina
-
National Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
University of NebraskaMillennium Pharmaceuticals, Inc.CompletedMantle Cell Lymphoma | Non-hodgkin's LymphomaUnited States
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
Jonsson Comprehensive Cancer CenterAstraZenecaRecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | Secondary Central Nervous System LymphomaUnited States
-
University of WashingtonRecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin LymphomaUnited States
-
Amgen Research (Munich) GmbHCompletedNon-Hodgkin's Lymphoma, RelapsedGermany
-
NCIC Clinical Trials GroupCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaMacedonia, The Former Yugoslav Republic of
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaSpain, France, United Kingdom, Germany, Australia, Italy
-
Hoffmann-La RocheCompletedA Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
BiogenTerminatedLymphoma, Non-Hodgkin's
-
BiogenTerminated
-
French Innovative Leukemia OrganisationUnknown
-
French Innovative Leukemia OrganisationUnknown
-
BiogenTerminatedLymphoma, Non-Hodgkin'sUnited States
-
Azienda Ospedaliera San Giovanni BattistaUnknownB-cell Lymphoma RefractoryItaly
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Mayo ClinicRecruitingIndolent B-Cell Non-Hodgkin Lymphoma | Recurrent Indolent Non-Hodgkin Lymphoma | Refractory Indolent Non-Hodgkin Lymphoma | Recurrent Indolent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
The First Affiliated Hospital of Soochow UniversityFundamenta Therapeutics, Ltd.RecruitingB Cell Lymphoma | CAR | Relapsed Non-Hodgkin LymphomaChina
-
BayerCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma | Lymphoma, Low-GradeJapan
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
Ascenta TherapeuticsCompletedFollicular LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingAggressive Non-Hodgkin LymphomaFrance, Belgium
-
He HuangGracell Biotechnology Ltd.Not yet recruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina